Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen Concentrate vs Cryoprecipitate in Neonatal CPB
NCT03932240Phase 3Completed
- Sponsor
- Emory University
- Start
- Aug 2019
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Fibrinogen human in coagulopathy (2 arms), sponsored by Emory University. Primary endpoint: Clot Degradation at 24 Hours Post-operatively. Started Aug 2019; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT03932240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03932240.